Rock Springs Capital Management as of June 30, 2019
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 135 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UnitedHealth (UNH) | 5.2 | $144M | 591k | 244.01 | |
Gw Pharmaceuticals Ads | 3.8 | $104M | 605k | 172.39 | |
WellCare Health Plans | 3.3 | $91M | 321k | 285.07 | |
Amarin Corp Spons Adr New (AMRN) | 3.2 | $88M | 4.5M | 19.39 | |
Neurocrine Biosciences (NBIX) | 3.1 | $86M | 1.0M | 84.43 | |
Intuitive Surgical Com New (ISRG) | 2.9 | $80M | 153k | 524.55 | |
Hca Holdings (HCA) | 2.2 | $62M | 455k | 135.17 | |
Pacira Pharmaceuticals (PCRX) | 2.0 | $54M | 1.3M | 43.49 | |
Spark Therapeutics | 1.9 | $52M | 505k | 102.38 | |
Encompass Health Corp (EHC) | 1.8 | $51M | 805k | 63.36 | |
Sarepta Therapeutics (SRPT) | 1.8 | $49M | 325k | 151.95 | |
Bristol Myers Squibb (BMY) | 1.7 | $48M | 1.1M | 45.35 | |
EXACT Sciences Corporation (EXAS) | 1.7 | $47M | 397k | 118.04 | |
Teleflex Incorporated (TFX) | 1.6 | $43M | 130k | 331.15 | |
Boston Scientific Corporation (BSX) | 1.5 | $42M | 970k | 42.98 | |
Coherus Biosciences (CHRS) | 1.5 | $42M | 1.9M | 22.10 | |
Irhythm Technologies (IRTC) | 1.4 | $40M | 500k | 79.08 | |
Penumbra (PEN) | 1.4 | $38M | 239k | 160.00 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $37M | 203k | 183.38 | |
Acadia Healthcare (ACHC) | 1.3 | $37M | 1.1M | 34.95 | |
Ultragenyx Pharmaceutical (RARE) | 1.3 | $37M | 580k | 63.50 | |
Stryker Corporation (SYK) | 1.3 | $37M | 179k | 205.58 | |
Edwards Lifesciences (EW) | 1.2 | $34M | 184k | 184.74 | |
IDEXX Laboratories (IDXX) | 1.2 | $33M | 120k | 275.33 | |
Alexion Pharmaceuticals | 1.1 | $32M | 243k | 130.98 | |
Radius Health Com New | 1.1 | $31M | 1.3M | 24.36 | |
Molina Healthcare (MOH) | 1.1 | $30M | 206k | 143.14 | |
Insulet Corporation (PODD) | 1.1 | $29M | 245k | 119.38 | |
Medicines Company | 1.1 | $29M | 800k | 36.47 | |
Blueprint Medicines (BPMC) | 1.0 | $29M | 308k | 94.33 | |
Adaptive Biotechnologies Cor (ADPT) | 1.0 | $29M | 600k | 48.30 | |
Align Technology (ALGN) | 1.0 | $29M | 105k | 273.70 | |
Cigna Corp (CI) | 1.0 | $29M | 182k | 157.55 | |
Portola Pharmaceuticals | 1.0 | $27M | 1.0M | 27.13 | |
Madrigal Pharmaceuticals (MDGL) | 1.0 | $27M | 257k | 104.81 | |
Beigene Sponsored Adr (BGNE) | 1.0 | $27M | 215k | 123.95 | |
Incyte Corporation (INCY) | 1.0 | $27M | 312k | 84.96 | |
Invitae (NVTAQ) | 1.0 | $26M | 1.1M | 23.50 | |
Argenx Se Sponsored Adr (ARGX) | 0.9 | $26M | 182k | 141.58 | |
Baxter International (BAX) | 0.9 | $25M | 301k | 81.90 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 0.9 | $25M | 214k | 115.15 | |
Ra Pharmaceuticals | 0.9 | $24M | 804k | 30.07 | |
Pra Health Sciences | 0.9 | $24M | 240k | 99.15 | |
Thermo Fisher Scientific (TMO) | 0.9 | $24M | 81k | 293.68 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $24M | 328k | 72.56 | |
Epizyme | 0.8 | $23M | 1.9M | 12.55 | |
Biogen Idec Call Option (BIIB) | 0.8 | $23M | 98k | 233.87 | |
Insmed Com Par $.01 (INSM) | 0.8 | $23M | 890k | 25.60 | |
Galapagos Nv Spon Adr (GLPG) | 0.8 | $21M | 165k | 128.93 | |
Mirati Therapeutics | 0.8 | $21M | 203k | 103.00 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $21M | 1.6M | 13.15 | |
Zai Lab Adr (ZLAB) | 0.7 | $19M | 550k | 34.87 | |
Retrophin | 0.7 | $19M | 950k | 20.09 | |
Phasebio Pharmaceuticals | 0.7 | $19M | 1.4M | 13.12 | |
Alder Biopharmaceuticals | 0.7 | $18M | 1.6M | 11.77 | |
Intersect Ent | 0.7 | $18M | 790k | 22.76 | |
Allakos (ALLK) | 0.6 | $18M | 404k | 43.33 | |
West Pharmaceutical Services (WST) | 0.6 | $17M | 138k | 125.15 | |
Celgene Corporation | 0.6 | $17M | 185k | 92.44 | |
Sage Therapeutics (SAGE) | 0.6 | $17M | 93k | 183.09 | |
Seattle Genetics | 0.6 | $17M | 242k | 69.21 | |
Guardant Health (GH) | 0.6 | $16M | 190k | 86.33 | |
Axonics Modulation Technolog (AXNX) | 0.6 | $16M | 400k | 40.97 | |
Odonate Therapeutics Ord | 0.6 | $16M | 430k | 36.69 | |
Audentes Therapeutics | 0.6 | $16M | 410k | 37.86 | |
Biohaven Pharmaceutical Holding | 0.5 | $15M | 344k | 43.79 | |
Global Blood Therapeutics In | 0.5 | $14M | 265k | 52.60 | |
Fibrogen (FGEN) | 0.5 | $14M | 306k | 45.18 | |
Agilent Technologies Inc C ommon (A) | 0.5 | $14M | 183k | 74.67 | |
Translate Bio | 0.5 | $13M | 1.0M | 12.63 | |
Nevro (NVRO) | 0.5 | $13M | 196k | 64.83 | |
Obseva Sa | 0.5 | $13M | 1.1M | 11.31 | |
Amicus Therapeutics (FOLD) | 0.5 | $13M | 1.0M | 12.48 | |
Immunomedics | 0.4 | $12M | 895k | 13.87 | |
Novocure Ord Shs (NVCR) | 0.4 | $12M | 195k | 63.23 | |
Anaptysbio Inc Common (ANAB) | 0.4 | $12M | 219k | 56.42 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $12M | 143k | 85.65 | |
Axogen (AXGN) | 0.4 | $12M | 604k | 19.80 | |
Zogenix Com New | 0.4 | $11M | 235k | 47.78 | |
Rigel Pharmaceuticals Com New | 0.4 | $11M | 4.2M | 2.61 | |
Abbvie (ABBV) | 0.4 | $11M | 150k | 72.72 | |
Freshpet (FRPT) | 0.4 | $11M | 235k | 45.51 | |
Theravance Biopharma (TBPH) | 0.3 | $9.0M | 550k | 16.33 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $8.5M | 171k | 49.88 | |
Homology Medicines | 0.3 | $8.3M | 425k | 19.57 | |
RTI Biologics | 0.3 | $8.3M | 2.0M | 4.25 | |
Karuna Therapeutics Ord | 0.3 | $8.3M | 414k | 20.02 | |
Achillion Pharmaceuticals | 0.3 | $7.9M | 3.0M | 2.68 | |
Assembly Biosciences | 0.3 | $7.6M | 560k | 13.49 | |
Dermira | 0.3 | $7.4M | 775k | 9.56 | |
Puma Biotechnology (PBYI) | 0.2 | $6.8M | 534k | 12.71 | |
Cymabay Therapeutics | 0.2 | $6.4M | 900k | 7.16 | |
Spero Therapeutics (SPRO) | 0.2 | $6.0M | 525k | 11.51 | |
Bluebird Bio (BLUE) | 0.2 | $6.0M | 47k | 127.19 | |
Insmed Note 1.750% 1/1 (Principal) | 0.2 | $5.8M | 6.0M | 0.97 | |
Mersana Therapeutics (MRSN) | 0.2 | $5.7M | 1.4M | 4.05 | |
Anthem (ELV) | 0.2 | $5.6M | 20k | 282.20 | |
Aeglea Biotherapeutics | 0.2 | $5.5M | 800k | 6.85 | |
Ardelyx (ARDX) | 0.2 | $5.4M | 2.0M | 2.69 | |
Global Cord Blood Corporatio SHS (CORBF) | 0.2 | $5.3M | 925k | 5.78 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $5.2M | 235k | 22.00 | |
Ngm Biopharmaceuticals | 0.2 | $5.1M | 351k | 14.64 | |
Macrogenics (MGNX) | 0.2 | $5.1M | 300k | 16.97 | |
Gamida Cell SHS | 0.2 | $5.1M | 1.0M | 5.08 | |
Medicines Note 2.750% 7/1 (Principal) | 0.2 | $5.0M | 5.0M | 1.01 | |
Momenta Pharmaceuticals | 0.2 | $5.0M | 400k | 12.45 | |
Chiasma | 0.2 | $4.9M | 650k | 7.47 | |
Alder Biopharmaceuticals Note 2.500% 2/0 (Principal) | 0.2 | $4.7M | 5.0M | 0.93 | |
Aclaris Therapeutics (ACRS) | 0.2 | $4.4M | 2.0M | 2.19 | |
Akero Therapeutics (AKRO) | 0.2 | $4.3M | 225k | 19.15 | |
Compugen Ord (CGEN) | 0.2 | $4.2M | 1.1M | 3.84 | |
Restorbio | 0.1 | $4.1M | 400k | 10.20 | |
Myovant Sciences | 0.1 | $4.1M | 450k | 9.05 | |
Intercept Pharmaceuticals In | 0.1 | $4.0M | 50k | 79.58 | |
La Jolla Pharmaceutical Com Par $.0001 2 | 0.1 | $3.9M | 425k | 9.25 | |
Nabriva Therapeutics SHS | 0.1 | $3.9M | 1.6M | 2.43 | |
Clovis Oncology | 0.1 | $3.8M | 256k | 14.87 | |
Medicines Note 2.500% 1/1 (Principal) | 0.1 | $3.6M | 3.0M | 1.21 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $3.5M | 875k | 4.02 | |
Arvinas Ord (ARVN) | 0.1 | $3.3M | 150k | 21.99 | |
Five Prime Therapeutics | 0.1 | $3.2M | 526k | 6.03 | |
Dynavax Technologies Corp Com New (DVAX) | 0.1 | $2.6M | 650k | 3.99 | |
Correvio Pharma Corp | 0.1 | $2.6M | 1.2M | 2.16 | |
Paratek Pharmaceuticals | 0.1 | $1.8M | 450k | 3.99 | |
Corvus Pharmaceuticals (CRVS) | 0.1 | $1.5M | 400k | 3.74 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.91 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.32 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.3M | 1.5M | 0.86 | |
Kaleido Biosciences Ord (KLDO) | 0.0 | $1.2M | 100k | 11.60 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.0M | 1.0M | 1.03 | |
Novavax Com New (NVAX) | 0.0 | $952k | 163k | 5.86 | |
Dermira Note 3.000% 5/1 (Principal) | 0.0 | $865k | 1.0M | 0.86 | |
Covetrus | 0.0 | $788k | 32k | 24.45 | |
Heron Therapeutics (HRTX) | 0.0 | $558k | 30k | 18.60 | |
Proteostasis Therapeutics In | 0.0 | $390k | 400k | 0.97 |